CN105998189A - Tablet health care product containing multivitamins and application of tablet health care product - Google Patents

Tablet health care product containing multivitamins and application of tablet health care product Download PDF

Info

Publication number
CN105998189A
CN105998189A CN201610302034.5A CN201610302034A CN105998189A CN 105998189 A CN105998189 A CN 105998189A CN 201610302034 A CN201610302034 A CN 201610302034A CN 105998189 A CN105998189 A CN 105998189A
Authority
CN
China
Prior art keywords
vitamin
grams
tablet health
health care
care product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610302034.5A
Other languages
Chinese (zh)
Inventor
徐艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Mingkuan Information Advisory Center
Original Assignee
Nanjing Mingkuan Information Advisory Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Mingkuan Information Advisory Center filed Critical Nanjing Mingkuan Information Advisory Center
Priority to CN201610302034.5A priority Critical patent/CN105998189A/en
Publication of CN105998189A publication Critical patent/CN105998189A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicine, and discloses a tablet health care product containing multivitamins. Active ingredients contained in the tablet health care product are prepared from, by weight, 1.2 g of 4,000 international unit of vitamin A, 125 g of calcium carbonate, 1.6 g of vitamin B, 1.8 g of vitamin B2, 2.6 g of vitamin B6, 500 g of roots of stephania graciliflora Yamamoto, 400 g of roots of streptocaulon griffithii Hook.f., 500 g of herb of lycopodium annotinum L. and 600 g of main trunks of cyathea spinulosa Wall., and the active ingredients and other traditional Chinese medicine form a compound. The invention further discloses application of the tablet health care product in preparation of drugs for inhibiting mouse lymphoma Yac-1 cell proliferation.

Description

A kind of tablet health product containing compound vitamin and application thereof
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to a kind of tablet health product containing compound vitamin.
Background technology
Compound vitamin is used for curing fatigue, and prevention is because of the vitamin deficiency caused by dietary unbalance.Sport-utility is transported for a long time " loss " of prevention vitamin (A, B, D, PP) when moving or train.Risk is felt sick, vomiting, skeleton pain.Someone Think that common people pass through normal meals, it is possible to reach Chinese Soclety of Nutrition to vitamin and the recommended intake of mineral, meet The needs of health, need not take nutrient prime replenisher.Up to now, people the most do not find that it suppresses mouse lymph lymphoma Yac-1 The effect of cell proliferation.
Summary of the invention
Goal of the invention: in order to solve the problems referred to above, it is an object of the invention to provide a kind of tablet health product containing compound vitamin.
Technical scheme: it is an object of the invention to by following scheme realization:
A kind of tablet health product containing compound vitamin, its contained active component is extracted preparation by following raw materials in part by weight medicine proportioning Form: 4000 iu vitamin A 1.2 grams, calcium carbonate 125 grams, vitamin B1 1.6 grams, vitamin B2 1.8 Gram, vitamin B6 2.6 grams, XIANHUA Radix Stephaniae Japonicae 500g, Radix Streptocauli Griffithii 400g, adhesion separation grass 500g, flying apsaras 600g.
The described tablet health product containing compound vitamin, preparation method step is: takes above-mentioned XIANHUA Radix Stephaniae Japonicae, Radix Streptocauli Griffithii, divide Muscle grass, flying apsaras medical material merge, boiling twice, collecting decoction, and when being concentrated into 65 DEG C, relative density is 1.10-1.20, Add ethanol, stirring, make alcohol content by volume percentage calculation reach 65-85%, stand, filter, filtrate reduced in volume to 65 DEG C Time relative density be 1.20-1.30 and reclaim ethanol, by concentrated solution be spray-dried, gained granular powder is broken into dry extract, add Vitamin A, calcium carbonate, vitamin B1, vitamin B2, vitamin B6 and adjuvant, pelletize, tabletting and get final product.
The described tablet health product containing compound vitamin, in preparation method, decocting condition is: amount of water is medical material weight for the first time 8-12 times amount, decoct 1-2h, amount of water is the 6-10 times amount of medical material weight for the second time, decoct 1-2h.
The described tablet health product containing compound vitamin, in preparation method, spray drying condition is: inlet temperature is 90-110 DEG C, Leaving air temp is 60-90 DEG C, and temperature of charge is 60-90 DEG C, and atomizing pressure is 0.2-0.5 MPa, and spray velocity is 1-10ml/s.
The application in preparation suppression mouse lymph lymphoma Yac-1 cell proliferation of the described tablet health product containing compound vitamin.
XIANHUA Radix Stephaniae Japonicae is Menispermaceae stephania plant XIANHUA Radix Stephaniae Japonicae Stephania graciliflora Yamamoto, enters with root Medicine.Autumn and winter excavate, and clean chopping, dry.Induce sweat, stomach invigorating, pain relieving, antiinflammatory.For catching a cold, stomatitis, laryngitis, stomach Bitterly, asthma.
Radix Streptocauli Griffithii is that trailing plants rattan Ke Malian saddle platymiscium horse connects saddle Streptoculon griffithii Hook.f. and is used as medicine with root.The whole year can adopt, Using fresh herb or dry use.Heat-clearing and toxic substances removing, scattered silt pain relieving.For cat fever, enteritis, dysentery, stomachache, treating swelling and pain by traumatic injury, poisonous snake Bite.
Adhesion separation grass is that fern Lycopodiaceae Lycopodium plant China fir climing Lycopodium clavatum Lycopodium annotinum L. is with all herbal medicine.The four seasons can Adopt, dry or dry in the shade.Expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation.For traumatic injury, waist-leg bones and muscles pain, rheumatic numbness.
Flying apsaras is Cyatheaceae Caulis cyatheae spinulosae platymiscium Caulis cyatheae spinulosae Cyathea spinulosa Wall., is used as medicine with trunk.The whole year can adopt, and cuts Removing the hard crust of trunk, section is dried.Expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, clearing and antitussive.For rheumatic arthritis, traumatic injury damages Wound, chronic bronchitis, cough due to lung-heat, oedema due to nephritis, prevents influenza；Put on the skin outside juice in stem and control ringworm.
Beneficial effect: XIANHUA Radix Stephaniae Japonicae, Radix Streptocauli Griffithii heat-clearing and toxic substances removing in we, scattered silt pain relieving is monarch drug, adhesion separation grass, flying apsaras Expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation is ministerial drug, and all medicines are harmonious, and play heat-clearing and toxic substances removing, benefiting QI for activating blood circulation altogether, are used for suppressing mouse lymph lymphoma Yac-1 cell proliferation.
Detailed description of the invention
Form by the following examples, is described in further detail the foregoing of the present invention again, but should this not understood Scope for the above-mentioned theme of the present invention is only limitted to Examples below, and all technology realized based on foregoing of the present invention belong to this The scope of invention.
Embodiment 1: take XIANHUA Radix Stephaniae Japonicae 500g, Radix Streptocauli Griffithii 400g, adhesion separation grass 500g, flying apsaras 600g medical material mixing, Boiling twice, add water 8 times amount into medical material weight for the first time, decocts 1.5h, and add water into medical material weight 6 times for the second time Amount, decocts 1h, collecting decoction, filters, and filtrate is concentrated into relative density 1.10 (65 DEG C), adds ethanol in proper amount and make alcohol content (body Fraction) reach 65%, stir, stand 24 hours, filter, filtrate recycling ethanol is also concentrated into relative density 1.10 (65 DEG C) Extractum, spray-dried (condition be inlet temperature be 100 DEG C, leaving air temp is 80 DEG C, and temperature of charge is 70 DEG C, mist Changing pressure is 0.2 MPa, and spray velocity is 5ml/s.), it is ground into dry extract, adds 4000 iu vitamin A 1.2 Gram, calcium carbonate 125 grams, vitamin B1 1.6 grams, vitamin B2 1.8 grams, vitamin B6 2.6 grams, dextrin 50g, with appropriate 80% ethanol wet, soft material processed, crosses 14 mesh sieves and pelletizes, and 70 DEG C are dried, and 60 mesh granulate, tabletting obtains tablet.
Embodiment 2: take XIANHUA Radix Stephaniae Japonicae 500g, Radix Streptocauli Griffithii 400g, adhesion separation grass 500g, flying apsaras 600g medical material mixing, Boiling twice, the 10 times amount into medical material weight that add water, decoct 2h, second time adds water 8 times amount into medical material weight, Decocting 1h, collecting decoction, filter, filtrate is concentrated into relative density 1.15 (65 DEG C), adds ethanol in proper amount and make alcohol content (volume Mark) reach 75%, stir, stand 24 hours, filter, filtrate recycling ethanol is also concentrated into relative density 1.25 (65 DEG C) Extractum, spray-dried (condition be inlet temperature be 120 DEG C, leaving air temp is 90 DEG C, and temperature of charge is 80 DEG C, mist Changing pressure is 0.3 MPa, and spray velocity is 7.5/s.), it is ground into dry extract, adds 4000 iu vitamin A 1.2 Gram, calcium carbonate 125 grams, vitamin B1 1.6 grams, vitamin B2 1.8 grams, vitamin B6 2.6 grams, starch 50g, mix homogeneously, with appropriate 80% ethanol wet, soft material processed, cross 30 mesh sieves and pelletize, be dried in 70～80 DEG C, with 60 Mesh sieve granulate, tabletting, obtain finished product.
Embodiment 3: take XIANHUA Radix Stephaniae Japonicae 500g, Radix Streptocauli Griffithii 400g, adhesion separation grass 500g, flying apsaras 600g medical material mixing, Boiling twice, add water 10 times amount into medical material weight for the first time, decocts 1.5h, and add water into medical material weight 8 for the second time Times amount, decocts 1.5h, collecting decoction, filters, and filtrate is concentrated into relative density 1.15 (65 DEG C), adds ethanol in proper amount and make containing alcohol Amount (volume fraction) reaches 75%, stirs, stands 24 hours, filters, and filtrate recycling ethanol is also concentrated into relative density 1.25 The extractum of (65 DEG C), spray-dried (condition be inlet temperature be 120 DEG C, leaving air temp is 90 DEG C, and temperature of charge is 90 DEG C, Atomizing pressure is 0.4 MPa, and spray velocity is 7.5/s.), it is ground into dry extract, crosses No. 6 sieves, add 4000 international single Position vitamin A 1.2 grams, calcium carbonate 125 grams, vitamin B1 1.6 grams, vitamin B2 1.8 grams, vitamin B6 2.6 Gram, dextrin 50g, with appropriate 80% ethanol wet, soft material processed, cross 14 mesh sieves and pelletize, 70 DEG C are dried, 60 mesh granulate, pressure Sheet obtains tablet.
Embodiment 4: the experimentation data of suppression mouse lymph lymphoma Yac-1 cell proliferation
Experiment cell strain: mouse lymph lymphoma Yac-1 cell, Nanjing Medical University's Experimental Animal Center laboratory cell storehouse, DMEM+10%FBS cellar culture.
Drugs: prepare by embodiment 1 method.
Medicinal liquid liquid storage: weigh the 100mg present invention, is dissolved in 5ml dehydrated alcohol, and 0.2 μm filter filters, 500 μ l doff Pipe subpackage ,-20 DEG C of storages, 0.2 μm filter filters dehydrated alcohol in case matched group is used simultaneously.
Experiment reagent: DMEM (GIBCO company Cat.No.12100-061Lot.No.758137)；Hyclone (Zhejiang Sky over the river Hangzhoupro bio tech ltd Lot.No.100419)；NaHCO3 (the long hundred million chemical reagent company limited Cat. in Shanghai No.11810-033 Lot.No.1088387)；Trypsin (AMRESCO company lot number: 2010/04)；EDTA (AMRESCO company lot number: 2009/10)；Penicillin G Sodium Salt (AMRESCO company lot number: 2010242)；Streptomycin Sulfate (AMRESCO company lot number: 2010382)；Dehydrated alcohol (Nanjing chemistry Reagent company limited lot number: 080310182)；MTT (Biosharp lot number: 0793)；PBS (laboratory autogamy)；
Experiment equipment: Lycra inverted microscope (Germany Leica model: DM1L)；Visible-ultraviolet light microwell plate detector is (beautiful MD company of state model: SPECTRA MAX 190)；CO2 incubator (FORMA model: 3111)；Super-clean bench (Soviet Union Safe and sound company of clean group manufactures model: SW-CJ-ZFD)；Pure water instrument (Spring company of U.S. model: S/N 020579)； Accurate pipettor (Gilson Inc of France model: P2)；Electronic balance (Sai Duolisi company limited of Germany model: BT323S)； Full-automatic high-pressure autoclave (SANYO company of Japan model: MLS-3020)；Table electrothermal air dry oven (upper Nereid Closely knit test equipment company's model: DHG9123A)；Refrigerator (Siemens Company's model: KG18V21TI)；Liquid nitrogen container (CBS Model: 2001)；Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000)；0.2 μm filter (MILLIPORE Model: SLGP033RB)；10cm culture dish (NEST company), 96 well culture plates (NEST company)；Cell counting count board； Centrifuge tube, pipet, Tips are some.
Experimental technique: 1) mouse lymph lymphoma Yac-1 cell DMEM+10%FBS in 37 DEG C, 5%CO2 carries out often Rule cultivate (10cm culture dish), when cell grows to logarithmic (log) phase, collect cell, discard culture fluid, and PBS rinses 3 times, Add 3ml 0.25% trypsin-0.04%EDTA, after 37 DEG C of digestion 2min, be added thereto to 5ml complete medium Neutralizing reaction, proceeded in centrifuge tube after piping and druming cell, 1000rpm is centrifuged 5min, adjusts concentration of cell suspension 3 × 104 Individual/ml.2) entering in 96 well culture plates by cell kind, every hole adds cell suspension 180 μ l, and culture plate puts into cell culture incubator In (37 DEG C, 5%CO2) cellar culture.3) according to cell growth status, general long to 50%-70%, add the present invention Solution, continues to cultivate 24h.4) add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT) after 24h, continue to cultivate 4h. 5) after 4h, buckle method removes supernatant, pats dry gently with absorbent paper, and every hole adds 200 μ l dimethyl sulfoxide, puts low speed on shaking table Vibration 10min, makes crystal fully dissolve.The light absorption value in each hole is measured at enzyme-linked immunosorbent assay instrument 490nm.6) simultaneously Background (being not added with cell, only add culture fluid) is set, control wells (cell, the medicine dissolution medium of same concentrations, culture fluid, MTT, dimethyl sulfoxide), often group sets 6 multiple holes.7) suppression ratio of cell is represented by result with medicine:
Cell proliferation suppression ratio (%)=(control wells OD value-dosing holes OD value)/control wells OD value × 100%.Experiment It is repeated 3 times.
Statistical disposition: using the correlation analysis in Microsoft Excel 2003 software and Student t inspection, data are with mean ± S.D. represents.
Experimental result: statistical result showed after mtt assay experiment, compares with matched group, when dosage reaches 5mg/ml, to greatly Ren Mus gland bites chromium glucagonoma PC12 cell inhibitory effect variant (P < 0.05), and dosage this difference when 10mg/ml has significantly Property (P < 0.01), has pole significant difference (P < 0.001) when dosage reaches 15-20mg/ml.
Table 1 present invention is to mouse lymph lymphoma Yac-1 cell inhibitory effect influence research (X ± SD)
Note: compare with matched group, * P < 0.01；**P<0.001
Experiment conclusion: the present invention can suppress mouse lymph lymphoma Yac-1 cell proliferation, reduces mouse lymph lymphoma Yac-1 cell Cell growing number, this effect is dose dependent.

Claims (5)

1. the tablet health product containing compound vitamin, it is characterised in that its contained active component is by following weight Part crude drug proportioning is extracted and is prepared from: 4000 iu vitamin A 1.2 grams, calcium carbonate 125 grams, vitamin B1 1.6 grams, vitamin B2 1.8 grams, vitamin B6 2.6 grams, XIANHUA Radix Stephaniae Japonicae 500g, Radix Streptocauli Griffithii 400g, Adhesion separation grass 500g, flying apsaras 600g.
2. contain the tablet health product of compound vitamin as claimed in claim 1, it is characterised in that preparation method step is: Take above-mentioned XIANHUA Radix Stephaniae Japonicae, Radix Streptocauli Griffithii, adhesion separation is careless, the medical material that flies to the sky merges, boiling twice, collecting decoction, When being concentrated into 65 DEG C, relative density is 1.10-1.20, adds ethanol, stirring, makes alcohol content by volume percentage calculation reach 65-85%, stands, and filters, and during filtrate reduced in volume to 65 DEG C, relative density is 1.20-1.30 and reclaims ethanol, by dense Contracting liquid is spray-dried, and gained granular powder is broken into dry extract, adds vitamin A, calcium carbonate, vitamin B1, dimension life Element B2, vitamin B6 and adjuvant, pelletize, tabletting and get final product.
3. contain the tablet health product of compound vitamin as claimed in claim 2, it is characterised in that preparation method decocts Condition is: amount of water is the 8-12 times amount of medical material weight for the first time, decocts 1-2h, and amount of water is medical material weight for the second time 6-10 times amount, decoct 1-2h.
4. contain the tablet health product of compound vitamin as claimed in claim 2, it is characterised in that preparation method is sprayed Drying condition is: inlet temperature is 90-110 DEG C, and leaving air temp is 60-90 DEG C, and temperature of charge is 60-90 DEG C, atomization Pressure is 0.2-0.5 MPa, and spray velocity is 1-10ml/s.
5. the tablet health product containing compound vitamin as claimed in claim 1 increase at suppression mouse lymph lymphoma Yac-1 cell Grow the application in medicine.
CN201610302034.5A 2016-05-09 2016-05-09 Tablet health care product containing multivitamins and application of tablet health care product Withdrawn CN105998189A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610302034.5A CN105998189A (en) 2016-05-09 2016-05-09 Tablet health care product containing multivitamins and application of tablet health care product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610302034.5A CN105998189A (en) 2016-05-09 2016-05-09 Tablet health care product containing multivitamins and application of tablet health care product

Publications (1)

Publication Number Publication Date
CN105998189A true CN105998189A (en) 2016-10-12

Family

ID=57099144

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610302034.5A Withdrawn CN105998189A (en) 2016-05-09 2016-05-09 Tablet health care product containing multivitamins and application of tablet health care product

Country Status (1)

Country Link
CN (1) CN105998189A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101816428A (en) * 2010-05-13 2010-09-01 山东森健生物科技发展有限公司 Health-care food capable of bringing human body balanced nutrition
CN103690646A (en) * 2013-12-11 2014-04-02 山东中大药业有限公司 Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicine for inhibiting mouse lymphoma cell YAC-1 cell proliferation
CN103735785A (en) * 2013-12-30 2014-04-23 孙亚平 Application of lespedeza cuneata turbidness-eliminating tablet to preparation of medicament for suppressing cell proliferation of lymphoma cells YAC-1
CN103735947A (en) * 2013-12-26 2014-04-23 赵鹏 Traditional Chinese medicinal prescription for treating osteoporosis and preparation method thereof
CN104306828A (en) * 2014-11-13 2015-01-28 山东中大药业有限公司 Preparation method of liver benefiting tablet containing nepal dock root and day lily and application of liver benefiting tablet to preparation of drug for restraining multiplication of lymphoma cell YAC-1 cell
CN104664533A (en) * 2015-03-21 2015-06-03 高萍 Preparation method of health beverage
CN104857143A (en) * 2015-06-03 2015-08-26 陈爱华 Medicinal preparation for improving anoxia endurance

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101816428A (en) * 2010-05-13 2010-09-01 山东森健生物科技发展有限公司 Health-care food capable of bringing human body balanced nutrition
CN103690646A (en) * 2013-12-11 2014-04-02 山东中大药业有限公司 Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicine for inhibiting mouse lymphoma cell YAC-1 cell proliferation
CN103735947A (en) * 2013-12-26 2014-04-23 赵鹏 Traditional Chinese medicinal prescription for treating osteoporosis and preparation method thereof
CN103735785A (en) * 2013-12-30 2014-04-23 孙亚平 Application of lespedeza cuneata turbidness-eliminating tablet to preparation of medicament for suppressing cell proliferation of lymphoma cells YAC-1
CN104306828A (en) * 2014-11-13 2015-01-28 山东中大药业有限公司 Preparation method of liver benefiting tablet containing nepal dock root and day lily and application of liver benefiting tablet to preparation of drug for restraining multiplication of lymphoma cell YAC-1 cell
CN104664533A (en) * 2015-03-21 2015-06-03 高萍 Preparation method of health beverage
CN104857143A (en) * 2015-06-03 2015-08-26 陈爱华 Medicinal preparation for improving anoxia endurance

Similar Documents

Publication Publication Date Title
CN103816368A (en) Extraction method and application of ginseng-containing plant composition
CN105769927A (en) Venenum Bufonis extraction method and Venenum Bufonis product
CN103599292B (en) A kind of preparation method of Guishaoliujun Pill and application
CN105030868A (en) Extraction method for plant composition containing silybum marianum and application of plant composition
CN105998083A (en) Arenobufagin extraction method and arenobufagin product
CN105998189A (en) Tablet health care product containing multivitamins and application of tablet health care product
CN103690751B (en) A kind of application of SHUXINNING PIAN and preparation method
CN103690601A (en) Application and preparation method of heart strengthening tablets
CN103721136B (en) A kind of preparation method of Yanyan slice and application
CN107114745A (en) A kind of LBP-X fruit honey and its preparation method and application
CN105726802A (en) Preparation method and application of Bazheng tablets
CN105194002A (en) Method for extracting plant composition containing echinacea and application of plant composition
CN105963550A (en) Extraction method of heparin sodium and heparin sodium product
CN105106570A (en) Extraction method and application of garlic-containing plant combination
CN103655923B (en) A kind of preparation method of Auricularia SHUJIN WAN and application
CN103638489B (en) Preparation method and application of kidney-tonifying pills
CN103656415A (en) Application of anti-pharyngitis tablet and preparation method thereof
CN105055587A (en) Extraction method and application of plant composition containing ginkgo leaves
CN103816258A (en) Traditional Chinese medicine composition for treating prostatic cancer as well as preparation method and application of composition
CN104906260A (en) Preparation method and application of wind-expelling and itching-relieving granule
CN104840797A (en) Preparation method and application of Yixuanning capsule
CN103638487B (en) A kind of preparation method of Babao Ruisheng pill and application
CN103585615A (en) Preparation method and application of clove and cardamom center-rectifying pill
CN105267681A (en) Extraction method and application of plant composition containing ginseng
CN105663312A (en) Preparation method and application of red sage root formula granules

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20161012

WW01 Invention patent application withdrawn after publication